BELGIUM, Wis., Feb. 20 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), a global health company that develops biotechnology based solutions for positive, long term benefit to the agricultural and consumer markets, announced today that it has closed on the acquisition of Modular Process Constructors LLC (MPC).
Mach One acquired 100% of the LLC interests of MPC for $500,000 of Series B convertible preferred stock at a conversion price of $0.50 cents per share. The purchase price was funded out of available authorized shares.
Monte B. Tobin, Chairman and Chief Executive Officer of Mach One, said, "This acquisition not only brings us the needed expertise to facilitate expansion of the animal division of our business model, it will be accretive to our revenues for 2009 as MPC obtains additional world class customers in the biopharmaceutical industry."
About Mach One Corporation
Mach One Corporation (www.machonecorp.com) is a global health company that provides biotechnology based solutions to help address one of the world's most pressing and costly needs--positive, long-term health and longevity benefits for disease-threatened animals of large commercial operations. Mach One provides broad spectrum immunoglobulin and nutraceutical products that offer a new level of cost effectiveness, improved health and ease of treatment--with an initial focus on the dairy industry. Mach One intends to fully leverage the potential of its breakthrough solutions--breakthroughs that one day will also include consumer applications.
About Modular Process Constructors, LLC
Modular Process Constructors currently designs and builds process equipment used by the biopharmaceutical industry. MPC's skid based solutions offer componentized fabrication for small and large projects reducing lead time, transport cost,
|SOURCE Mach One Corporation|
Copyright©2009 PR Newswire.
All rights reserved